These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Impact of margin status on outcomes after endoscopic resection of well-differentiated duodenal neuroendocrine tumors. Ragheb J; Mony S; Klapman J; Erim T; Reagan A; Butler R; Dong Y; Cruise M; Centeno BA; Bejarano P; Stevens T; Hayat U; Bhatt A Gastrointest Endosc; 2021 Sep; 94(3):580-588. PubMed ID: 33676923 [TBL] [Abstract][Full Text] [Related]
6. Duodenal neuroendocrine tumors: Impact of tumor size and total number of lymph nodes examined. Zhang XF; Wu XN; Tsilimigras DI; Poultsides G; Rocha F; Abbott DE; Fields R; Idrees K; Cho C; Maithel SK; Pawlik TM; J Surg Oncol; 2019 Dec; 120(8):1302-1310. PubMed ID: 31680243 [TBL] [Abstract][Full Text] [Related]
7. Outcomes of Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumours (NETs): a Systematic Review of the Literature. Dasari BVM; Al-Shakhshir S; Pawlik TM; Shah T; Marudanayagam R; Sutcliffe RP; Mirza DF; Muiesan P; Roberts KJ; Isaac J J Gastrointest Surg; 2018 Sep; 22(9):1652-1658. PubMed ID: 29869091 [TBL] [Abstract][Full Text] [Related]
8. Survival outcomes and surgical intervention of small intestinal neuroendocrine tumors: a population based retrospective study. Wu L; Fu J; Wan L; Pan J; Lai S; Zhong J; Chung DC; Wang L Oncotarget; 2017 Jan; 8(3):4935-4947. PubMed ID: 27903960 [TBL] [Abstract][Full Text] [Related]
9. Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database. Assi HA; Mukherjee S; Kunz PL; Machiorlatti M; Vesely S; Pareek V; Hatoum H Oncologist; 2020 Feb; 25(2):e276-e283. PubMed ID: 32043766 [TBL] [Abstract][Full Text] [Related]
10. Survival comparison between endoscopic and surgical resection for non-ampullary duodenal neuroendocrine tumor (1-2 cm). Xie J; Zhang Y; He M; Liu X; Xie P; Pang Y Sci Rep; 2022 Sep; 12(1):15339. PubMed ID: 36097200 [TBL] [Abstract][Full Text] [Related]
11. Comparisons of therapeutic outcomes in patients with nonampullary duodenal neuroendocrine tumors (NADNETs): A multicenter retrospective study. Lee SW; Sung JK; Cho YS; Bang KB; Kang SH; Kim KB; Kim SH; Moon HS; Song KH; Kim SM; Chung IK; Lee DS; Jeong HY; Youn SJ Medicine (Baltimore); 2019 Jun; 98(26):e16154. PubMed ID: 31261543 [TBL] [Abstract][Full Text] [Related]
12. Duodenal neuroendocrine tumors: Somewhere between the pancreas and small bowel? Gamboa AC; Liu Y; Lee RM; Zaidi MY; Staley CA; Kooby DA; Winer JH; Shah MM; Russell MC; Cardona K; Maithel SK J Surg Oncol; 2019 Dec; 120(8):1293-1301. PubMed ID: 31621090 [TBL] [Abstract][Full Text] [Related]
13. A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis. Margonis GA; Samaha M; Kim Y; Postlewait LM; Kunz P; Maithel S; Tran T; Berger N; Gamblin TC; Mullen MG; Bauer TW; Pawlik TM J Gastrointest Surg; 2016 Jun; 20(6):1098-105. PubMed ID: 27008594 [TBL] [Abstract][Full Text] [Related]
14. Effects of endoscopic therapy and surgical resection on long-term survival outcomes in patients with duodenal gastrointestinal stromal tumors: a surveillance, epidemiology, and end result program analysis. Yan H; Liu X; Yin L; Han H; Jin Y; Zhu X; Liu Z Surg Endosc; 2022 Nov; 36(11):8030-8038. PubMed ID: 35437643 [TBL] [Abstract][Full Text] [Related]
15. Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors. Untch BR; Bonner KP; Roggin KK; Reidy-Lagunes D; Klimstra DS; Schattner MA; Fong Y; Allen PJ; D'Angelica MI; DeMatteo RP; Jarnagin WR; Kingham TP; Tang LH J Gastrointest Surg; 2014 Mar; 18(3):457-62; discussion 462-3. PubMed ID: 24448999 [TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature. Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372 [TBL] [Abstract][Full Text] [Related]
17. Conventional endoscopic mucosal resection versus modified endoscopic mucosal resection for duodenal neuroendocrine tumor. Noh JH; Kim DH; Park K; Na HK; Ahn JY; Lee JH; Jung KW; Choi KD; Song HJ; Lee GH; Jung HY Surg Endosc; 2023 May; 37(5):3884-3892. PubMed ID: 36717428 [TBL] [Abstract][Full Text] [Related]
18. Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors. Gincul R; Ponchon T; Napoleon B; Scoazec JY; Guillaud O; Saurin JC; Ciocirlan M; Lepilliez V; Pioche M; Lefort C; Adham M; Pialat J; Chayvialle JA; Walter T Endoscopy; 2016 Nov; 48(11):979-986. PubMed ID: 27494453 [No Abstract] [Full Text] [Related]
19. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors. Jung HJ; Hong SJ; Han JP; Kim HS; Jeong GA; Cho GS; Kim HK; Ko BM; Lee MS J Dig Dis; 2015 Oct; 16(10):595-600. PubMed ID: 26315879 [TBL] [Abstract][Full Text] [Related]